STOCK TITAN

Aehr Test Systems (AEHR) director gifts 500 shares to charity

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Aehr Test Systems director Laura Oliphant donated 500 shares of common stock on August 4, 2026 as a bona fide gift to USA Triathlon Foundation. The transaction carried a reported per-share price of $0.0000, so no sale proceeds were received. Following the donation, she directly owns 17,817 shares, which include shares subject to unvested restricted stock units.

Positive

  • None.

Negative

  • None.
Insider OLIPHANT LAURA
Role Director
Type Security Shares Price Value
Gift Common Stock F1, F2 500 $0.00 $0.00
Holdings After Transaction: Common Stock — 17,817 shares (Direct)
Footnotes (2)
  1. F1. The shares were donated to USA Triatholon Foundation.
  2. F2. The amount reported includes shares subject to unvested restricted stock units.
Shares gifted 500 shares Bona fide gift of common stock on August 4, 2026
Shares owned after transaction 17,817 shares Direct holdings after the gift, including shares subject to unvested RSUs
Gift price per share $0.0000 per share Reported transaction price for the 500 donated shares
bona fide gift regulatory
"transaction code G is described as a bona fide gift of shares"
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
restricted stock units financial
"The amount reported includes shares subject to unvested restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
unvested restricted stock units financial
"shares subject to unvested restricted stock units are counted in the total"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did AEHR director Laura Oliphant report?

Laura Oliphant reported a bona fide gift of 500 shares of Aehr Test Systems common stock. The donation occurred on August 4, 2026, and the shares were given to the USA Triathlon Foundation, with a reported per-share transaction price of $0.0000.

How many AEHR shares does Laura Oliphant own after this gift?

After the reported gift, Laura Oliphant directly owns 17,817 AEHR shares. This total, as disclosed, includes shares subject to unvested restricted stock units, meaning not all of the reported holdings are currently vested and freely tradable.

Who received the donated AEHR shares from Laura Oliphant?

The 500 donated AEHR shares were given to the USA Triathlon Foundation. This charitable recipient is specified in the transaction footnote, confirming the disposition was a charitable stock donation rather than a sale or transfer for consideration.

Did Laura Oliphant sell any AEHR shares for cash in this Form 4?

No, the filing shows no cash sale of AEHR shares by Laura Oliphant. The 500-share transaction is coded as a bona fide gift with a reported price of $0.0000 per share, indicating no sale proceeds were received.

Are Laura Oliphant’s reported AEHR holdings fully vested?

No, the reported 17,817 AEHR shares include shares subject to unvested restricted stock units. This means part of her disclosed holdings will vest over time according to the company’s equity award terms rather than being immediately unrestricted.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
OLIPHANT LAURA

(Last)(First)(Middle)
C/O AEHR TEST SYSTEMS
400 KATO TERRACE

(Street)
FREMONT CALIFORNIA 94539

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
Director
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/04/2026G500(1)D$017,817(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The shares were donated to USA Triatholon Foundation.
2. The amount reported includes shares subject to unvested restricted stock units.
Remarks:
/s/Chris Siu, Attorney-in-Fact08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)